You are here

  • Home
  • Archive
  • Volume 5, Issue 2
  • Gemfibrozil reduced the risk for coronary events in men with coronary artery disease and low levels of high density lipoprotein cholesterol

Article Text

Article menu
Download PDFPDF
Therapeutics
Gemfibrozil reduced the risk for coronary events in men with coronary artery disease and low levels of high density lipoprotein cholesterol

https://doi.org/10.1136/ebm.5.2.49

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Sources of funding: Veterans Affairs Office of Research and Development and Parke-Davis.

    • For correspondence: Dr HB Rubins, Section of General Internal Medicine (111O), Veterans Affairs Medical Center, Minneapolis, MN 55417, USA. Fax +1 612 725 2118.

    • ↵* See glossary.

    • ↵† Information provided by author.